MoonLake Immunotherapeutics (MLTX): Weighted Average Diluted Shares
64.46M
Year ended 2025-12-31
+30.0%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 64.46M | +2.5% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | 62.87M | +28.0% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | 49.12M | +67.3% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | 29.36M | -91.8% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | 360.00M | n/a | 2022-02-17, From 2021-01-01 |